Finance

Lists
Why is 524500 down 3,10%?
Dive Deeper
524500:BOM
Kilitch Drugs (India) Ltd
229,85 INR
-3,10%
(-7,35) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524500...
Open
249,00 INR
High
249,00 INR
Low
227,55 INR
Mkt. cap
8,06 მლრდ.
Avg. vol.
8,51 ათ.
Volume
4,02 ათ.
P/E ratio
26,36
52-wk high
267,90 INR
52-wk low
121,10 INR
EPS
8,72 INR
Shares outstanding
15,36 მლნ.
No. of employees
236
Open
249,00 INR
High
249,00 INR
Low
227,55 INR
Mkt. cap
8,06 მლრდ.
Avg. vol.
8,51 ათ.
Volume
4,02 ათ.
P/E ratio
26,36
52-wk high
267,90 INR
52-wk low
121,10 INR
EPS
8,72 INR
Shares outstanding
15,36 მლნ.
No. of employees
236
News stories
From web sources and news partners
About Kilitch Drugs (India) Ltd
CEO-
Employees236
Founded1978
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
489,24 მლნ.
538,08 მლნ.
896,03 მლნ.
448,79 მლნ.
Cost of goods sold
263,62 მლნ.
308,88 მლნ.
447,19 მლნ.
237,18 მლნ.
Cost of revenue
263,62 მლნ.
308,88 მლნ.
447,19 მლნ.
237,18 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
90,30 მლნ.
88,94 მლნ.
95,23 მლნ.
93,34 მლნ.
Operating expense
183,84 მლნ.
177,06 მლნ.
224,31 მლნ.
193,19 მლნ.
Total operating expenses
447,46 მლნ.
485,93 მლნ.
671,50 მლნ.
430,36 მლნ.
Operating income
41,78 მლნ.
52,15 მლნ.
224,52 მლნ.
18,42 მლნ.
Other non operating income
66,60 მლნ.
15,28 მლნ.
-101,14 მლნ.
28,97 მლნ.
EBT including unusual items
93,99 მლნ.
55,96 მლნ.
202,11 მლნ.
38,63 მლნ.
EBT excluding unusual items
93,99 მლნ.
55,96 მლნ.
174,31 მლნ.
38,63 მლნ.
Income tax expense
13,59 მლნ.
12,81 მლნ.
53,28 მლნ.
18,96 მლნ.
Effective tax rate
14,46%
22,89%
26,36%
49,07%
Other operating expenses
84,92 მლნ.
78,74 მლნ.
127,70 მლნ.
88,92 მლნ.
Net income
81,90 მლნ.
44,32 მლნ.
145,18 მლნ.
29,13 მლნ.
Net profit margin
16,74%
8,24%
16,20%
6,49%
Earnings per share
-
-
-
-
Interest and investment income
-
-
5,47 მლნ.
-
Interest expense
-14,40 მლნ.
-11,47 მლნ.
-14,44 მლნ.
-8,76 მლნ.
Net interest expenses
-14,40 მლნ.
-11,47 მლნ.
-8,97 მლნ.
-8,76 მლნ.
Depreciation and amortization charges
8,63 მლნ.
9,37 მლნ.
1,38 მლნ.
10,93 მლნ.
EBITDA
50,31 მლნ.
57,40 მლნ.
231,03 მლნ.
24,93 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები